Omios Biologics
PrivateLast Round
Pre Seed
Oct 1, 2025
Company Overview
Omios Biologics is a biotechnology company developing next-generation oncolytic virus immunotherapies to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omios Biologics Comps
Public and private peers based on sector, stage, and business model.
Omios Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 1, 2025 |
Omios Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NYU Langone Health Venture Fund | Pre Seed |
| FuturePlay | Pre Seed |
| NYU Innovation Venture Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Led by FuturePlay and NYU Langone Health Venture Fund.
Omios Biologics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Omios Biologics's valuation, stock price, and market status.
